SG146623A1 - Rodent expression systems utilising polyoma virus and epstein barr virus sequences - Google Patents

Rodent expression systems utilising polyoma virus and epstein barr virus sequences

Info

Publication number
SG146623A1
SG146623A1 SG200806623-5A SG2008066235A SG146623A1 SG 146623 A1 SG146623 A1 SG 146623A1 SG 2008066235 A SG2008066235 A SG 2008066235A SG 146623 A1 SG146623 A1 SG 146623A1
Authority
SG
Singapore
Prior art keywords
expression systems
epstein barr
expression
rodent
virus
Prior art date
Application number
SG200806623-5A
Other languages
English (en)
Inventor
Noelle-Anne Sunstrom
Rajkumar Kunaparaju
Original Assignee
Acyte Biotec Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004901233A external-priority patent/AU2004901233A0/en
Application filed by Acyte Biotec Pty Ltd filed Critical Acyte Biotec Pty Ltd
Publication of SG146623A1 publication Critical patent/SG146623A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16211Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16211Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/22011Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/22011Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22041Use of virus, viral particle or viral elements as a vector
    • C12N2710/22043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/108Plasmid DNA episomal vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
SG200806623-5A 2003-09-09 2004-09-09 Rodent expression systems utilising polyoma virus and epstein barr virus sequences SG146623A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50165503P 2003-09-09 2003-09-09
AU2004901233A AU2004901233A0 (en) 2004-03-10 A mammalian expression system

Publications (1)

Publication Number Publication Date
SG146623A1 true SG146623A1 (en) 2008-10-30

Family

ID=34275871

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200806623-5A SG146623A1 (en) 2003-09-09 2004-09-09 Rodent expression systems utilising polyoma virus and epstein barr virus sequences

Country Status (5)

Country Link
US (1) US7919270B2 (de)
EP (1) EP1664312B1 (de)
AU (1) AU2004270765B2 (de)
SG (1) SG146623A1 (de)
WO (1) WO2005024030A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790446B2 (en) * 2005-02-11 2010-09-07 Kosagen Cell Factory Oü Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
US8377653B2 (en) * 2005-02-11 2013-02-19 Icosagen Cell Factory Oü Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays
US7892790B2 (en) 2005-10-28 2011-02-22 Hoffmann-La Roche Inc. Protein expression in rodent cells
CN102124019B (zh) * 2007-01-25 2017-09-15 惠觅宙 鸡β肌动蛋白基因内含子1的用途
WO2009137911A1 (en) 2008-05-15 2009-11-19 National Research Counsil Of Canada Process, vectors and engineered cell lines for enhanced large-scale transfection
EP2243836A1 (de) 2009-04-22 2010-10-27 Amarna Therapeutics B.V. Verfahren zur Herstellung von rekombinanten Polymavirus-Vektorenteilchen
EP2964749A4 (de) * 2013-03-08 2016-08-17 Neuclone Biolog Pty Ltd Zellkulturmedienzusammensetzung und verfahren zur herstellung davon
AU2014225272B2 (en) 2013-03-08 2015-10-22 Neuclone Biologics Pty Ltd A cell expression system
WO2015118146A1 (en) 2014-02-10 2015-08-13 Univercells Nv System, apparatus and method for biomolecules production
KR101971614B1 (ko) * 2019-01-10 2019-04-23 한국생명공학연구원 목적 단백질의 생산이 증가된 세포주 및 이를 이용한 목적 단백질 생산 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798105A (en) * 1990-06-06 1998-08-25 University Of Nijmegan DNA encoding a plasmodium 16kD protein
US5374515A (en) * 1992-11-13 1994-12-20 Organogenesis, Inc. In vitro cornea equivalent model

Also Published As

Publication number Publication date
EP1664312A1 (de) 2006-06-07
US7919270B2 (en) 2011-04-05
EP1664312A4 (de) 2007-07-18
WO2005024030A1 (en) 2005-03-17
US20050227317A1 (en) 2005-10-13
AU2004270765A1 (en) 2005-03-17
AU2004270765B2 (en) 2010-03-04
EP1664312B1 (de) 2011-07-27

Similar Documents

Publication Publication Date Title
ATE412761T1 (de) Methode um rekombinante proteine in cho zellen zu exprimieren
MX2010007729A (es) Vectores de expresion de mamifero mejorados y uso de los mismos.
MX2015004649A (es) Metodos de modificacion de celulas huesped.
EA201792340A2 (ru) Способ получения рекомбинантного adamts13 в культуре клеток
WO2006050138A3 (en) Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use
DK1623023T3 (da) Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra
DK1474507T3 (da) Fremgangsmåder og materialer til produktion af organiske produkter i celler af Candida arter
ATE549395T1 (de) Medium und kultur von embryonalen stammzellen
IL163180A (en) Growing populations of renewable hematopoietic stem cells and their methods
DK1948789T3 (da) Fremgangsmåde til fremstilling af permanente, humane cellelinjer
ATE437233T1 (de) Matrix-anheftungsregionen und verfahren zu deren verwendung
SG146623A1 (en) Rodent expression systems utilising polyoma virus and epstein barr virus sequences
DE602005021379D1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
ATE280239T1 (de) Homologe rekombination in eukaryotischen zellen mit inaktiviertem fehlpaarungsreparatur-system
WO2007084364A8 (en) Improved il-12 for expression in mammalian cells
DK1137808T3 (da) Fremgangsmåde til fremstilling af rekombinante celler
ATE326537T1 (de) Schnell erzeugung von stabilen säugertier- zellinien mit gewinnung eines hohen gehalts von recombinanten proteine
DK2010565T3 (da) Fremgangsmåde til produktion af rekombinant protein i CHO-celler
AU2008232699A8 (en) High expression clones of mammalian cells with fluorescent protein A or G
WO2004113515A3 (en) Tissue modeling in embryonic stem (es) cell system
DE60323267D1 (en) Rna-bioassay
SG151159A1 (en) Novel expression vector with enhanced gene expression capacity and method for using the same
DK1140149T3 (da) Anvendelse af humant væksthormon til forögelse af antallet af cirkulerende CD34+-celler, tilsigtet til genetablering af de hematopoietiske system og immunsystemet fölgende myeloablative eller antibalstiske terapier ved transplantation......
EA200101093A1 (ru) Экспрессия гепарин-связывающего протеина в рекомбинантных клетках млекопитающих
BRPI0415446A (pt) recombinação mediada por flp